PEAK
Get informed when a big investor buys or sells
+ FollowUndervalued by 1.7% based on the discounted cash flow analysis.
| Market cap | $9.36 Billion |
|---|---|
| Enterprise Value | $9.19 Billion |
| Dividend Yield | $1.20 (6.37%) |
| Earnings per Share | $0.1 |
| Beta | 1 |
| Outstanding Shares | 695,161,000 |
| P/E Ratio | 59.92 |
|---|---|
| PEG | 17.02 |
| Price to Sales | 4.28 |
| Price to Book Ratio | 1.32 |
| Enterprise Value to Revenue | 3.2 |
| Enterprise Value to EBIT | 17.33 |
| Enterprise Value to Net Income | 41 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.13 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
This committee's role in developing and scoring tax legislation is crucial. Its reports and technical expertise directly influence corporate tax structures, REIT-specific regulations, and the overall tax burden on industries and financial vehicles like Healthpeak Properties.
This powerful committee controls taxation, trade, and entitlement spending (e.g., Medicare). Its tax policy decisions directly impact Healthpeak Properties' REIT structure and its tenants' corporate valuations, while entitlement spending significantly affects revenue streams for healthcare tenants.
This committee regulates the FDA and NIH, directly impacting Healthpeak's life science tenants (drug approvals, research funding). It also influences labor laws, which affect the operational costs of all healthcare providers and senior living operators, who are key tenants for PEAK.
This committee's investigations into issues affecting older Americans, including drug pricing and long-term care quality, directly impact the profitability and regulatory environment for Healthpeak Properties' significant senior housing portfolio and related healthcare tenants.
This committee directly regulates the financial system (Fed, SEC) and real estate markets (HUD). As a REIT, Healthpeak Properties is inherently a financial vehicle operating in real estate, making this committee's oversight highly relevant to its funding, operations, and valuation.